GX CG7 (Malarone pediatric 62.5 mg / 25 mg)
Generic Name: atovaquone/proguanil
Pill imprint GX CG7 has been identified as Malarone pediatric 62.5 mg / 25 mg.
Malarone Pediatric is used in the treatment of malaria prevention; malaria and belongs to the drug class antimalarial combinations. Risk cannot be ruled out during pregnancy. Malarone Pediatric 62.5 mg / 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- GX CG7
- 62.5 mg / 25 mg
- 7.00 mm
- Prescription only
- Drug Class:
- Antimalarial combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- GSK Pharm
- National Drug Code (NDC):
- Inactive Ingredients:
- low substituted hydroxypropyl cellulose
sodium starch glycolate type A potato
polyethylene glycol 400
polyethylene glycol 8000
ferric oxide red
|NDC Code||Manufacturer / Repackager|
|68462-0563||Glenmark Pharmaceuticals Inc., USA|
Note: Inactive ingredients may vary.
More about Malarone Pediatric (atovaquone / proguanil)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.